Clinica de Marly (BOG:MARLY) Preferred Stock: COP0 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Clinica de Marly Preferred Stock?

Clinica de Marly BOG:MARLY Preferred Stock is COP0 Mil as of . 20.

Preferred stock is a special equity security that has properties of both equity and debt. Clinica de Marly's preferred stock for the quarter that ended in . 20 was COP0 Mil.

The market value of preferred stock needs to be added to the market value of common stocks in the calculation of Enterprise Value. Clinica de Marly's Enterprise Value for the quarter that ended in . 20 was COP0 Mil.

In the calculation of book value, the par value of preferred stocks needs to subtracted from total equity. Clinica de Marly's Book Value per Share for the quarter that ended in . 20 was COP.

Dividends paid to preferred stocks need to be subtracted from net income in the calculation of Earnings per Share (Diluted). Clinica de Marly's Earnings per Share (Diluted) for the three months ended in . 20 was COP.


Clinica de Marly  (BOG:MARLY) Preferred Stock Explanation

When a company needs capital but does not wish to issue debt, they may sell preferred stocks to investors.

For instance, during the financial crisis of 2008, Goldman Sachs (GS) issued a combination of preferred stock and common stock options for $5 billion of capital to Warren Buffett’s Berkshire Hathaway (BRK.A)(BRK.B). In this deal, Berkshire Hathaway paid $5 billion for 10% cumulative perpetual preferred stock and warrants to buy 43.5 million shares of Goldman Sachs at $115 a share. Goldman Sachs bought back the preferred in 2010. Guess how much money Warren Buffett made in this deal in two years? Read How Much Did Warren Buffett’s Berkshire Hathaway (BRK.B) Make on Its Goldman Sachs (GS) Preferred Stock?

1. The market value of Preferred Stocks needs to be added to the market value of common stocks in the calculation of enterprise value.

Clinica de Marly's Enterprise Value for the quarter that ended in . 20 is calculated as

2. In the calculation of Book Value, the par value of Preferred Stocks needs to subtracted from total equity.

Clinica de Marly's Book Value per Share for the quarter that ended in . 20 is calculated as

3. Dividends paid to Preferred Stocks need to be subtracted from net income in the calculation of earnings per share.

Clinica de Marly's Earnings per Share (Diluted) (EPS) for the three months ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinica de Marly Preferred Stock Related Terms


Clinica de Marly Preferred Stock Historical Data

* Premium members only.

The historical data trend for Clinica de Marly's Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clinica de Marly Preferred Stock Chart

Clinica de Marly Annual Data
Trend
Preferred Stock

Clinica de Marly Quarterly Data
Preferred Stock

Clinica de Marly Preferred Stock Calculation

Preferred Stock is a special equity security that has properties of both equity and debt. It is generally considered a hybrid instrument. Preferred stock is senior to common stock, but is subordinate to bonds in terms of claim or rights to their share of the assets of the company.

Preferred stock has priority over common stock in the payment of dividends and any payments received when a company liquidates.

Preferred stock comes in many forms. It can be:


Convertible or Non-Convertible
Cumulative or Non-Cumulative
Voting or Non-Voting
Callable or Non-Callable
Maturity Date or No Maturity Date

A preferred stock without a maturity date is called a perpetual preferred stock. These are relatively rare. A good example of perpetual preferred stock is the many series of Public Storage (PSA) preferred shares that trade on the New York Stock Exchange.

Before investing in preferred stock, it is important to know which of the above groups the stock belongs to. Is it convertible or non-convertible? Are dividends cumulative or non-cumulative?

It is also critical that an investor knows what bonds the company has in front of the preferred stock. Bondholders get paid first. So the decision to buy a preferred stock can be similar to the decision to buy a bond. But, remember, the preferred stock of a company with bonds is junior to those bonds.

Unless a preferred stock is convertible, the upside in a preferred stock investment is more limited than in a common stock investment. If a company doubles its earnings, it is usually under no more obligation to double the dividends paid to preferred shareholders than it is to double the interest paid to its bankers and bondholders.So preferred stock is very different from common stock.

Frequently Asked Questions Learn more about Preferred Stock →
What does a Preferred Stock of COP0 Mil mean?
Clinica de Marly (BOG:MARLY) has a Preferred Stock of COP0 Mil as of . 20. Preferred Stock represents the par value of a company's preferred shares. View historical data on Clinica de Marly and its competitors.
Is Clinica de Marly's Preferred Stock too high?
Clinica de Marly's current Preferred Stock is COP0 Mil.
How does Clinica de Marly's Preferred Stock compare to SPIN and USNU?
Clinica de Marly's Preferred Stock of COP0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Stock for a Healthcare Providers & Services company?
A good Preferred Stock depends on the Healthcare Providers & Services industry context. However, Preferred Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Stock mean?
A high Preferred Stock can signal that a stock is expensive relative to its fundamentals. Preferred Stock represents the par value of a company's preferred shares. View historical data on Clinica de Marly and its competitors. Clinica de Marly's current Preferred Stock is COP0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinica de Marly stock overvalued right now?
Clinica de Marly (BOG:MARLY) has a current Preferred Stock of COP0 Mil. The current Preferred Stock is COP0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Stock calculated?
Preferred Stock is calculated from a company's financial statements. For Clinica de Marly (BOG:MARLY), the current Preferred Stock is COP0 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clinica de Marly Business Description

Address Calle 50 No. 9-67, Bogota, COL
Clinica de Marly SA provides healthcare services in Colombia. Its services includes anesthesia and pain clinic, blood bank, blood densitometry, bone marrow transplant, cardiology, clinic laboratory, dentistry, emergency, and external consultation.